GLP-1R is widely distributed throughout the body, including the pancreas, central nervous system, gastrointestinal tract, cardiovascular system, and adipose tissue ( In our previous studies, we highlighted that abnormal lipid metabolism is closely associated with kidney allograft fibrosis, and we found CPT1A is a critical target in treatment of kidney allograft fibrosis ( To date, research on GLP-1R/GCGR agonists in the treatment of kidney fibrosis remains limited, and the effects of GLP-1R or GCGR agonists on kidney allograft fibrosis have not been investigated
( [17] ) During the shortages, compounding pharmacies produced off-label copies of semaglutide and tirzepatide, but those emergency measures ceased as branded supply recovered.( [18] ) ( [19] ) Meanwhile, payer response to GLP-1 demand has varied
A generic frenzy
Additionally, weight loss itself can improve conditions such as obstructive sleep apnoea, potentially leading to better sleep quality over time